EODData

NASDAQ, INDV:

05 Sep 2025
LAST:

24.98

CHANGE:
 0.25
OPEN:
24.73
HIGH:
25.00
ASK:
0.00
VOLUME:
3.44M
CHG(%):
1.01
PREV:
24.73
LOW:
24.47
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Sep 2524.7325.0024.4724.983.44M
04 Sep 2524.8224.9824.6024.731.59M
03 Sep 2524.5824.9724.5424.672.26M
02 Sep 2524.4124.6524.0624.601.6M
29 Aug 2523.8924.3023.5924.281.74M
28 Aug 2524.3624.4623.8323.881.37M
27 Aug 2524.9025.0024.2624.362.04M
26 Aug 2524.0124.5223.3224.462.73M
25 Aug 2524.4424.6623.7024.011.67M
22 Aug 2524.1724.6424.0324.322.71M

COMPANY PROFILE

Name:
About:Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Sector:Healthcare
Address:10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235
Website:https://www.indivior.com
CIK:0001625297
ISIN:GB00BN4HT335
FIGI:BBG007T9F088
LEI:213800V3NCQTY7IED471

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:28.99
Price to Book:145.25
Price to Sales:2.50
EBITDA:336M
Shares:124.77M
Market Cap:3.117B

TECHNICAL INDICATORS

MA5:24.65
MA10:24.43
MA20:23.81
MA50:19.64
MA100:15.85
MA200:13.26
STO9:98.21
STO14:98.73
RSI14:71.23
MTM14:1.56
ROC14:0.07
ATR:0.68
Week High:25.00
Week Low:23.59
Month High:25.00
Month Low:21.16
Year High:25.00
Year Low:7.33

RECENT SPLITS

Date Ratio
17 Oct 20221-5

RECENT DIVIDENDS

Date Amount
16 Jun 2016$0.48
17 Sep 2015$0.16